Unraveling Druggable Targets in Epileptogenesis: Recent Advances.
INTRODUCTION Afflicting 50 million people worldwide, epilepsy accounts for a sizeable burden among neurological diseases. Its progression, termed epileptogenesis, and the sole availability of medications with negligible effects against its clinical course in the market render epilepsy largely incurable. As studies illu...